Continuous Use of Antithrombotic Medications during Peri-ESD Period for Colorectal Lesions: A Propensity Score Matched Study.
Keisuke KawasakiTakehiro TorisuMotohiro EsakiMakoto EizukaShinichiro KawatokoTomo KumeiMinami HiraiMasahiro KondoShin FujiokaYuta FuyunoYuichi MatsunoJunji UmenoTomohiko MoriyamaTakanari KitazonoTamotsu SugaiTakayuki MatsumotoPublished in: Journal of gastroenterology and hepatology (2023)
Continuation of antithrombotic medications during the peri-colorectal ESD period increases the risk of bleeding. However, the continuation may be acceptable under careful monitoring for post-ESD bleeding.